The conserved N-terminal SANT1-binding domain (SBD) of EZH2 regulates PRC2 activity
Authors:
- Agata L. PatriotisAPAgata L. Patriotis
- Douglas W. BarrowsDBDouglas W. Barrows
- Yadira Soto-FelicianoYSYadira Soto-Feliciano
- Laiba F. KhanLKLaiba F. Khan
- Marylene LeboeufMLMarylene Leboeuf
- Dylan M. MarchioneDMDylan M. Marchione
- Matthew R. MarundeMMMatthew R. Marunde
- Michael-Christopher KeoghMKMichael-Christopher Keogh
- Alexey A. SoshnevASAlexey A. Soshnev
Open Access
- 9 February 2026
- journal article
- Published by Cold Spring Harbor Laboratory in Genes & Development
- Vol. 40 (9-10) , 650-665
Abstract
Polycomb group proteins maintain gene expression patterns established during early development, with Polycomb repressive complex 2 (PRC2) methyltransferase being a key regulator of cell differentiation, identity, and plasticity. Consequently, extensive somatic mutations in PRC2, including gain or loss of function (GOF or LOF), are observed in human cancers. The regulation of chromatin structure by PRC2 is critically dependent on its enhancer of zeste homolog 2 (EZH2) subunit, which catalyzes the methylation of histone H3 lysine 27 (H3K27). Recent structural studies of PRC2 revealed extensive conformational changes in the noncatalytic EZH2 N-terminal SANT1-binding domain (SBD) during PRC2 activation, though the functional significance remains unclear. Here, we investigated how the SBD regulates PRC2 function. The domain is highly conserved in metazoans and dispensable for PRC2 assembly and chromatin localization yet is required for genome-wide histone H3K27 methylation. Furthermore, we show that an intact SBD is necessary for the proliferation of EZH2-addicted lymphomas, and its deletion in the presence of EZH2 GOF mutations inhibits cancer cell growth. These observations provide new insights into the regulation of PRC2 activity in normal development and malignancy.Keywords
All Related Versions
Funding Information
- Women and Science Fellowship Anderson Cancer Center Fellowship for Cancer Research
- National Cancer Institute (F99CA253687)
- Damon Runyon Cancer Research Foundation (DRSG 21-17)
- National Institutes of Health
- National Institute of General Medical Sciences (1K99GM140265)
- National Institute of General Medical Sciences (R01 CA234561)
- American Cancer Society (IRG-21-147-01-IRG)
- Cancer Prevention and Research Institute of Texas (RP240068)
- HIHR (RP240446)
- National Institutes of Health (P01CA196539)
- National Institutes of Health (5R01CA204639)
- Leukemia and Lymphoma Society (LLS-SCOR 7006-13)
- The Rockefeller University and St. Jude Children's Research Hospital Collaborative on Chromatin Regulation in Pediatric Cancer
This publication has 75 references indexed in Scilit:
- rtracklayer: an R package for interfacing with genome browsersBioinformatics, 2009
- AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2Nucleic Acids Research, 2009
- Dynamic Regulation by Polycomb Group Protein Complexes Controls Pattern Formation and the Cell Cycle in DrosophilaDevelopmental Cell, 2008
- Model-based Analysis of ChIP-Seq (MACS)Genome Biology, 2008
- Qualifying the relationship between sequence conservation and molecular functionGenome Research, 2008
- Extraction, purification and analysis of histonesNature Protocols, 2007
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007
- Polycomb complexes repress developmental regulators in murine embryonic stem cellsNature, 2006
- EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and BreastJournal of Clinical Oncology, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005